Duramed Pharmaceuticals, Inc.
🏢 View company profile →15Patents
7Active
15Granted
39Portfolio score
Filing activity: Jul 25, 1996 → Jun 23, 2011 · 6 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5908638A | Pharmaceutical compositions of conjugated estrogens and methods for their use | Human Necessities | 71 | Expired |
| US7459445B2 | Estrogenic compounds and topical pharmaceutical formulations of the same | Chemistry; Metallurgy | 59 | Active |
| US7749989B2 | Estrogenic compounds, methods of using and methods of administering the same | Chemistry; Metallurgy | 57 | Active |
| US8227454B2 | Estrogenic compounds, pharmaceutical compositions and formulations comprising the same | Chemistry; Metallurgy | 52 | Active |
| US7989436B2 | Estrogenic compounds and pharmaceutical formulations comprising the same | Chemistry; Metallurgy | 52 | Active |
| US7005138B2 | Method of systematically delivering SSRIs | Human Necessities | 27 | Expired |
| US7497331B2 | Child resistant package | Performing Operations; Transporting | 22 | Active |
| USRE39861E1 | Methods of extended use oral contraception | General | 15 | Expired |
| US6083532A | Sustained release formulation containing three different types of polymers and tablet formed therefrom | Human Necessities | 15 | Expired |
| US7320969B2 | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology | Human Necessities | 8 | Expired |
| US6346268B1 | Sustained release formulation containing three different types of polymers and tablet formed therefrom | Human Necessities | 6 | Expired |
| US7615545B2 | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology | Human Necessities | 4 | Active |
| US7556150B2 | Dispenser for progestin used for acute and maintenance treatment of DUB | Human Necessities | 2 | Active |
| US7078394B2 | Low dose estrogen interrupted hormone replacement therapy | Human Necessities | 1 | Expired |
| US7320970B2 | Low dose estrogen interrupted hormone replacement therapy | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.